World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03136133
Date of registration: 27/04/2017
Prospective Registration: Yes
Primary sponsor: Haukeland University Hospital
Public title: Protein Supplements to Cyclists
Scientific title: Effekt of Marine Peptide Supplementation on Recovery Following Endurance Cycling
Date of first enrolment: September 14, 2017
Target sample size: 16
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03136133
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Norway
Contacts
Name:     Trygve Hausken, MD
Address: 
Telephone: +4755972134
Email: trygve.hausken@helse-bergen.no
Affiliation: 
Name:     Trygve Hausken, MD
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Signed informed Consent

- The subject is a man between 40-50 years

- The subject has a body mass index (BMI) between 19-29

- Willing to comply with all study procedures and be available for the length of the
study

- In good general health as judged by the physician at the screening visit

Exclusion Criteria:

- The subject has had surgery or trauma with significant blood loss or has donated blood
within the last 3 months prior to the screening visit

- Diabetes type 1 or 2, or persistent high blood sugar levels

- The subject has tested positive for human immunodeficiency virus (HIV)

- Hepatitis B surface antigen (HBsAg), or hepatitis C virus antibody (anti-HCV)

- The subject has taken any investigational drugs within 1 month prior to screening

- Treated with antibiotics within 3 months prior to screening (oral, parenteral or
rectal), but not spray or ointment

- Treated with steroids within 1 month prior to screening (including oral treatment)

- Treated with medication that effects the intestinal function such as, H2- protonpump
inhibitors, diuretics, antiemetics, antidepressants, antacids,



Age minimum: 40 Years
Age maximum: 50 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Reconstitution After Bicycle Intervention
Intervention(s)
Dietary Supplement: Active protein drink
Primary Outcome(s)
Change in blood glucose compared to placebo [Time Frame: Change from baseline to every 30 minutes after dosing, for 2 hours]
Secondary Outcome(s)
Change in insulin-like peptide 5 compared to placebo [Time Frame: Change from baseline to every 30 minutes after dosing, for 2 hours]
Secondary ID(s)
2017/56
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Firmenich Bjørge Biomarine As
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history